ANAPLASTIC THYROID CANCER
Tracking # 20-888887
$99999.00
There are no ratings for this course
Learn moreCourse overview
ANAPLASTIC THYROID CARCINOMA, ALSO KNOWN AS UNDIFFERENTIATED THYROID CARCINOMA, IS A RARE, HIGHLY AGGRESSIVE MALIGNANT TUMOR ACCOUNTING FOR 2 TO 3 PERCENT OF ALL THYROID GLAND NEOPLASMS. ANAPLASTIC THYROID CARCINOMA CONTINUES TO BE ONE OF THE MOST DEADLY DISEASES WORLDWIDE AND CARRIES A VERY POOR PROGNOSIS. IN ADDITION TO CONSIDERABLE LOCAL INVASION, ANAPLASTIC THYROID CARCINOMA OFTEN PRESENTS WITH METASTATIC SPREAD TO REGIONAL LYMPH NODES AND DISTANT SITES. THIS ACTIVITY EXAMINES WHEN CLINICIANS SHOULD CONSIDER THIS CONDITION ON DIFFERENTIAL DIAGNOSIS AND HOW TO DIAGNOSE IT PROPERLY. THIS ACTIVITY HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE CARE OF PATIENTS WITH THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.